KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Deferred Tax Assets (2016 - 2018)

Historic Current Deferred Tax Assets for Idexx Laboratories (IDXX) over the last 10 years, with Q1 2018 value amounting to $30.4 million.

  • Idexx Laboratories' Current Deferred Tax Assets rose 5675.48% to $30.4 million in Q1 2018 from the same period last year, while for Mar 2018 it was $30.4 million, marking a year-over-year increase of 5675.48%. This contributed to the annual value of $23.5 million for FY2017, which is 3005.25% up from last year.
  • Idexx Laboratories' Current Deferred Tax Assets amounted to $30.4 million in Q1 2018, which was up 5675.48% from $23.5 million recorded in Q4 2017.
  • Idexx Laboratories' 5-year Current Deferred Tax Assets high stood at $39.8 million for Q4 2015, and its period low was $16.6 million during Q1 2016.
  • Its 5-year average for Current Deferred Tax Assets is $27.8 million, with a median of $30.4 million in 2018.
  • Its Current Deferred Tax Assets has fluctuated over the past 5 years, first plummeted by 5524.81% in 2016, then surged by 5675.48% in 2018.
  • Idexx Laboratories' Current Deferred Tax Assets (Quarter) stood at $37.7 million in 2014, then rose by 5.68% to $39.8 million in 2015, then plummeted by 54.59% to $18.1 million in 2016, then skyrocketed by 30.05% to $23.5 million in 2017, then increased by 29.06% to $30.4 million in 2018.
  • Its last three reported values are $30.4 million in Q1 2018, $23.5 million for Q4 2017, and $22.2 million during Q3 2017.